Karen Thudium Mueller PharmD, MS

Karen Thudium Mueller, PharmD, MS - Karen is a Clinical Pharmacologist at Novartis driving the clinical pharmacology strategy for the CAR-T portfolio. Karen contributed to the Kymriah ODAC and recent approval. Karen joined Novartis is 2011 and has supported early and late stage programs with a focus in biologics and cell and gene therapies. Karen completed a 2-year Post-Doctoral Fellowship at the University at Buffalo and Roswell Park Cancer Institute and is a graduate of the University of Rhode Island with a Doctorate in Pharmacy and a Master of Science in Clinical Pharmacokinetics. In her free time, Karen enjoys traveling, boating and spending time with her family.